[1]JournaloftheAmericanChemicalSociety,1991,vol.113,p.6187-6196
[2]AgriculturalandBiologicalChemistry,1988,vol.52,p.121-128
[3]JournalofMedicinalChemistry,1995,vol.38,p.2349-2356
[1]Patent:US5221746,1993,A
[2]Patent:US5310745,1994,A
[3]Patent:US5622972,1997,A
[4]Patent:US5003072,1991,A
[5]Patent:US5144037,1992,A
Title: Role of protein kinase C in the reduction of infarct size by N-methyl-1-deoxynojirimycin, an alpha-1,6-glucosidase inhibitor.
Journal: British journal of pharmacology 20010701
Title: Combination of N-methyl-1-deoxynojirimycin and ischemic preconditioning markedly reduces the size of myocardial infarcts in rabbits.
Journal: Japanese circulation journal 20010701
Title: N-alkylated nitrogen-in-the-ring sugars: conformational basis of inhibition of glycosidases and HIV-1 replication.
Journal: Journal of medicinal chemistry 19950623
Title: Inhibition of HIV replication by amino-sugar derivatives.
Journal: FEBS letters 19880912
Title: Arai M, et al. N-methyl-1-deoxynojirimycin (MOR-14), an alpha-glucosidase inhibitor, markedly reduced infarct size in rabbit hearts. Circulation. 1998 Apr 7;97(13):1290-7.
Title: Arai M, et al. Role of protein kinase C in the reduction of infarct size by N-methyl-1-deoxynojirimycin, an alpha-1,6-glucosidase inhibitor. Br J Pharmacol. 2001 Jul;133(5):635-42.
Title: Nishida Y, et al. N-methyl-1-deoxynojirimycin (MOR-14), an alpha-glucosidase inhibitor, markedly improves postischemic left ventricular dysfunction. Heart Vessels. 2000;15(6):268-73.
